Cristina Rebordosa

7PUBLICATIONS
32CO-AUTHORS
PharmacogenomicsEpidemiological modellingForensic epidemiologyToxicology (incl. clinical toxicology)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 23, 2026
Evaluating Arrhythmia Risk in Patients with Chronic Obstructive Pulmonary Disease Treated with Aclidinium/Formoterol Fumarate and Other Inhaled Bronchodilators: A Post-Authorization Safety Study.

Cristina Rebordosa, Jaume Aguado, Jennifer Bartsch

|Jan 18, 2024
Liver, renal, genitourinary and diabetic ketoacidosis risks among new users of empagliflozin versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Post-authorization safety study based on multinational cohorts.

Cristina Rebordosa, Reimar W Thomsen, Arlene K Tave

|Aug 26, 2022
Risk of Major Cardiovascular and Cerebrovascular Events in Users of Lisdexamfetamine and Other Medications for Attention-Deficit/Hyperactivity Disorder in Denmark and Sweden: A Population-Based Cohort Study.

Joan Forns, Elena Dudukina, David Hägg

|Aug 09, 2022
Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists.

Cristina Rebordosa, Estel Plana, Annalisa Rubino

|Mar 23, 2022
Cardiovascular events and all-cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long-acting beta2-agonists.

Cristina Rebordosa, Dóra Körmendiné Farkas, Jukka Montonen

|Mar 15, 2022
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany.

Elena Rivero-Ferrer, Morten Olesen, Estel Plana

Pageof 2

Frequent Collaborators

5 joint publications

Jaume Aguado

3 joint publications

Elena Rivero-Ferrer

3 joint publications

Estel Plana

3 joint publications

Núria Saigí-Morgui